Clinical Trials in Denver

Showing 9121-9140 of 18,161 trials

Effect of Two Exercise Programs on Bone Strength and Architecture

NCT02636530

Bone responds according to the load placed on it. In this study, investigators want to know if exercise that loads the body in exercises, like walking or jogging (Ground Reaction Forces: GRF), affects bone differently than exercises that load the joints, like weight lifting (Joint Reaction Forces: JRF). Participants will exercise at least 3 times a week for 6 months. Measures of bone strength and mass, muscular strength, and aerobic fitness will be taken at the beginning and the end of the 6 month program. Period blood samples will be taken for future analysis of blood markers.

Osteoporosis

University of Colorado, Denver48 participantsStarted Jul 2016

Aurora, Colorado, United States • Denver, Colorado, United States

COMPLETEDPhase 3< 1 mile

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

NCT03268005

The study compares 2 medicines for type 2 diabetes: fast-acting insulin aspart (a new medicine) and NovoRapid®/NovoLog® (a medicine doctors can already prescribe). Fast-acting insulin aspart will be tested to see how well it works and if it is safe. Participants will get either fast-acting insulin aspart or NovoRapid®/ NovoLog® - which treatment you get is decided by chance. Both medicines will be taken together with insulin degludec. Participants will need to take 1 injection 4 times every day (all insulins will be provided in pens). The study will last for about 8 months (34 weeks).

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S1,264 participantsStarted Sep 2017

Concord, California, United States • Fresno, California, United States • Fullerton, California, United States +164 more locations

Effect of Two Exercise Programs on Bone Strength and Architecture

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

Find Trials by Condition in Denver

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Phase 4 IOP Signals Associated With ILUVIEN®

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Clinical Study of a Diagnostic Device for NG, TV and CT in Women

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

Early Coronary Angiography Versus Delayed Coronary Angiography

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

ERAS® Guidelines Validation of CRS With or Without HIPEC

Comparative Bioavailability of Risperidone.

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

A Study of CNSA-001 in Women With Diabetic Gastroparesis

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1